SNV-001
- Generic Name
- SNV-001
- Brand Names
- Xenleta
Overview
No overview information available.
Background
No background information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
Xenleta
Manufacturer:Nabriva Therapeutics US, Inc.
Route:ORAL
Strength:600 mg in 1 1
Approved: 2021/10/13
NDC:72000-110
Xenleta
Manufacturer:Nabriva Therapeutics US, Inc.
Route:INTRAVENOUS
Strength:150 mg in 15 mL
Approved: 2021/10/13
NDC:72000-120
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath